We are neuroscience innovators.

We aim to identify, acquire, and develop a collection of high-potential technologies addressing a broad range of neurological and psychiatric disorders and advance them through approval and commercialization. Our decisions to advance projects are based on fundamental analyses of the science, clinical data, regulatory path, commercial viability, and, above all else: our ability to serve patients and caregivers.

As a Blackstone Life Sciences portfolio company, Neurvati is powered by best-in-class expertise, relentless passion, and deep resources to optimize the development of neuroscience therapeutics. We engage hand-picked strategic partners to broaden our reach while aligning ourselves with patient communities to enhance the development of treatments capable of transforming the lives of patients.

Therapeutics

Neuroscience

Life Sciences

Health Care

Neurvati Neurosciences

Bruce Leuchter

Pierre Jacquet

Mariann Dinunzio

Jonathan Freeman

Elliott Ruiz

Lindsay Goldberg

Jason Lettiere

Megan Weaver

Neurvati Neurosciences

Org chart

Teams

Similar companies